WallStreetZenWallStreetZen

NASDAQ: LPCN
Lipocine Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Lipocine earnings were -$9.3M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. The latest LPCN earnings report on Sep 30, 2026 announced Q3 2026 earnings of -$666.2k, down 74.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LPCN reported annual earnings of -$9.6M, with -115,371.9% growth.

LPCN earnings history

Current Revenue
$3.7M
Current Earnings
-$9.3M
Current Profit Margin
-249.2%

LPCN Return on Equity

Current Company
-46.5%
Current Industry
-17.8%
Current Market
37.1%
LPCN's Return on Equity (-46.5%)... subscribe to Premium to read more.
High Return on Equity Performance

LPCN Return on Assets

Current Company
-41.8%
Current Industry
-7.5%
LPCN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LPCN announces earnings.

LPCN Return on Capital Employed

Current Company
-44.09%
Current Industry
-5.1%
LPCN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LPCN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LPCN-$9.27M-$9.33MN/A-$1.36
CNTX-$43.73M-$43.89MN/A-$0.46
QNRX-$19.49M-$19.59MN/AN/A
KTTA-$20.64M-$21.29MN/A-$1.58
COCP-$9.89M-$9.94MN/A-$0.76
View Top Biotech Stocks

Lipocine Earnings Reports & History FAQ

What were Lipocine's earnings last quarter?

On LPCN's earnings call on Nov 5, 2026, Lipocine (NASDAQ: LPCN) reported Q3 2026 earnings per share (EPS) of -$0.08, up 86.44% year over year. Total LPCN earnings for the quarter were -$666.19 thousand. In the same quarter last year, Lipocine's earnings per share (EPS) was -$0.59.

If you're new to stock investing, here's how to buy Lipocine stock.

Is Lipocine profitable or losing money?

As of the last Lipocine earnings report, Lipocine is currently losing money. Lipocine's net profit (also called net income) for the twelve months ending Sep 30, 2026 was -$9.33 million, a 70.42% increase year over year.

What was LPCN's earnings growth in the past year?

As of Lipocine's earnings date in Nov 5, 2026, Lipocine's earnings has grown year over year. LPCN earnings in the past year totalled -$9.33 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.